ROMIPLOSTIM AS A PREPARATION TREATMENT BEFORE SPLENECTOMY IN PATIENTS WITH IMMUNE THROMBOCYTOPENIA.
EHA Library, Eva Burnasheva, 100120
TOWARD BETTER PATHOPHYSIOLOGICAL CHARACTERIZATION AND THERAPEUTIC SOLUTION IN BETA-THALASSEMIA TRAIT PATIENTS WITH IRON OVERLOAD. PRELIMINARY REPORTS FROM AN ONGOING STUDY.
EHA Library, Fabiana Busti, 100121
DIAGNOSTIC VALUE OF TESTS USED AT IMMUNE THROMBOCYTOPENIA DIAGNOSIS TO DETECT ASSOCIATED DISEASES. A PROSPECTIVE MULTICENTER COHORT STUDY.
EHA Library, Guillaume Moulis, 100122
EVALUATION OF EMERGENCY CARE FOR ADULT SICKLE CELL PATIENTS: A MONOCENTRIC STUDY
EHA Library, Marie-Agnes Azerad, 100123
PROSPECTIVE STUDY ON THE EFFECT OF FOK-I GENE POLYMORPHISM ON BONE HEALTH IN YOUNG PATIENTS WITH B-THALASSAEMIA MAJOR
EHA Library, Marina Economou, 100124
GROWTH DIFFERENTIATION FACTOR-15 AND CARDIOVASCULAR DISEASE IN THALASSEMIA INTERMEDIA
EHA Library, AZZA ABDELGAWAD TANTAWY ZAGHLOUL, 100125
THE P2Y12 H1 HAPLOTYPE IS ASSOCIATED WITH IMPAIRED ADP INDUCED AGGREGATION IN TWO PATIENTS WITH PLATELET-TYPE BLEEDING DIATHESIS.
EHA Library, Giannoula Soufla, 100126
ORAL IRON-BASED PHOSPHATE BINDER, FERRIC CITRATE, INCREASES IRON MEASURES IN DIALYSIS-DEPENDENT AND NON-DIALYSIS DEPENDENT PATIENTS WITH CHRONIC KIDNEY DISEASE
EHA Library, Lisa Loram, 100127
DO WE HAVE TO CHELATE PATIENTS WITH THALASEMIA MAJOR HAVING FERRITIN LEVELS < 500 ΜG/L ?
EHA Library, Gonul AYDOGAN, 100128
THINKING OF HEREDITARY XEROCYTOSIS: THE FIRST STEP TO THE DIAGNOSIS
EHA Library, Mónica Santos, 100129
IN VITRO FACTOR VIII ACTIVITY AFTER RECONSTITUTION WITH DILUENT FLUID FOR CONTINUOUS INFUSION
EHA Library, Kunsoo Lee, 100130
FREQUENCY AND CHARACTERISTICS OF FACTOR VIII INHIBITORS IN TUNISIAN HEMOPHILIA A : EXPERIENCE OF A SINGLE CENTER
EHA Library, Olfa Kassar, 100131
12 NOVEL MUTATIONS IDENTIFIED IN PATIENTS OF CONGENITAL AFIBRINOGENEMIA IN PAKISTAN.
EHA Library, Tehmina Nafees Sonia Khan, 100132
EFFICACY AND SAFETY OF PROPHYLAXIS IN PREVIOUSLY UNTREATED PATIENTS WITH SEVERE HEMOPHILIA A IN IRAN
EHA Library, Mehran Karimi, 100133
DISTRIBUTION OF THE ALLELES HLA II CLASS IN UKRAINIAN HEMOPHILIA A PATIENTS, DEPENDING ON THE INHIBITORS.
EHA Library, Oleksandra Stasyshyn, 100134
ASSOCIATION OF THE DYNAMIC STATUS OF COAGULATION FACTORS WITH L-ASPARAGINASE ADMINISTRATION IN THE INDUCTION PHASE OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOBLASTIC LYMPHOMA
EHA Library, Yasuo Kubota, 100135
RECURRENCES AFTER SPLANCHNIC VENOUS THROMBOSIS: RISK FACTORS AND EFFECT OF DIFFERENT TREATMENTS IN A RETROSPECTIVE MONOCENTER COHORT OF 154 PATIENTS.
EHA Library, Valerio De Stefano, 100136
THE ROLE OF TREGS AND TIM3 IN HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Caixia Li, 100137
SUCCESSFUL STEM CELL MOBILIZATION AND AUTOLOGOUS STEM CELL TRANSPLANTATION AFTER PRETREATMENT CONSISTING OF BENDAMUSTINE, PREDNISONE AND BORTEZOMIB IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
EHA Library, Wolfram Poenisch, 100138
ADAMTS-13 A NOVAL MARKER LINKING BETWEEN MICRO AND MACRO- VASCULAR DISEASE IN YOUNG TYPE -1 DIABETES PATIENTS
EHA Library, AZZA ABDELGAWAD TANTAWY ZAGHLOUL, 100139
PROGNOSTIC SIGNIFICANCE OF THE ABSOLUTE MONOCYTE COUNTS IN LUNG CANCER PATIENTS WITH VENOUS THROMBOEMBOLISM
EHA Library, Gyeong-Won Lee, 100140
CRP, D-DIMER, LEUKOCYTE, BLAST AND PLATELET COUNTS AT THE TIME OF ALL DIAGNOSIS AS POSSIBLE BIOMARKERS FOR EARLY CEREBRAL VEIN THROMBOSIS
EHA Library, Saara Mertanen, 100141
CHILDREN WITH CEREBRAL INFARCT DUE TO CRANIOCERVICAL ARTERIAL DISSECTION IN A SINGLE CENTER
EHA Library, Selin Aytac, 100142
A BESPOKE ‘APP’ FOR THE INVESTIGATION AND MANAGEMENT OF DEEP VEIN THROMBOSIS
EHA Library, Sheena Patel, 100143
OUTCOMES OF CORD BLOOD TRANSPLANTATION WITH NON-TOTAL BODY IRRADIATION CONDITIONING REGIMEN CONSISTING OF FLUDARABINE AND BUSULFAN FOR PATIENTS WITH ADVANCED HEMATOLOGYIC MALIGNANCIES
EHA Library, Kenji Tsuda, 100144
A PORTABLE MICROSCOPIC CELL COUNTER (ADAM II) FOR ENUMERATING CD34+ CELLS
EHA Library, Jong HyunOh, 100145
AUTOLOGOUS STEM CELL TRANSPLANT IN AL AMYLOIDOSIS: AN EFFECTIVE TREATMENT FOR SELECTED PATIENTS
EHA Library, Mariella d adda, 100146
TROUGH LEVEL MONITORING OF INTRAVENOUS BUSULFAN TO ESTIMATE THE AREA UNDER THE PLASMA DRUG CONCENTRATION-TIME CURVE IN PEDIATRIC HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS
EHA Library, Takuro Nishikawa, 100147
A BENDAMUSTINE CONTAINING FLUDARABIN-BASED REDUCED INTENSITY CONDITIONING FOR ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN REFRACTORY/RELAPSED CLASSICAL HODGKIN LYMPHOMA
EHA Library, Natalia Mikhaylova, 100148
EFFICACY OF ORAL GLUTAMINE IN THE PREVENTION OF MUCOSITIS IN PATIENTS UNDERGOING HEMATOPOIETIC STEM CELL TRANSPLANTATION. EXPERIENCE OF A SINGLE CENTER.
EHA Library, Ana Santamaria, 100149
THIOTEPA FOR AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AHSCT) IN SOLID TUMORS
EHA Library, Ritsuro Suzuki, 100150
BUSULFAN THERAPEUTIC DRUG MONITORING IS NEEDED IN POPULATIONS WITH GENETIC HETEROGENEITY UNDERGOING ALLOGENEIC STEM CELL TRANSPLANTATION
EHA Library, Murtadha Al-Khabori, 100151
HEMATOLOGICAL RECOVERY AFTER INTRA-BONE MARROW CORD-BLOOD TRANSPLANT WAS ENHANCED THROUGH LOCAL ENGRAFTMENT OF INJECTED SITE. A SINGLE CENTER PROSPECTIVE PHASE I/II TRIAL IN JAPAN.
EHA Library, Naoki Kurita, 100152
RETROSPECTIVE AUDIT OF A SINGLE CENTRE USE OF FRESH FROZEN PLASMA WITH OR WITHOUT PLASMA EXCHANGE TO REDUCE ISOAGGLUTININ TITRES PRIOR TO MAJOR ABO MISMATCHED HAEMATOPOIETIC STEM CELL TRANSPLANTS
EHA Library, Moon Ley Tung, 100153
BONE MARROW EOSINOPHILIA CORRELATES WITH TREATMENT OUTCOMES BOTH AFTER AUTOLOGOUS AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
EHA Library, Yanitsa Georgieva, 100154
AUTOLOGOUS PERIPHERAL BLOOD HEMATOPOIETIC STEM CELL TRANSPLANTATION (HSCT) FOR MULTIPLE MYELOMA WITHOUT CRYOPRESERVATION OF STEM CELL,SINGLE CENTER EXPERIENCE
EHA Library, Mani Ramzi, 100155
IMMUNOPHENOTYPIC CHARACTERIZATION OF HUMAN MOBILIZED HEMATOPOIETIC STEM AND PROGENITOR CELLS: BIOLOGICAL AND CLINICAL IMPLICATIONS.
EHA Library, Valentina Giai, 100156
QUALITY OF LIFE OF ANTICOAGULATED PATIENTS: SURVEY SATISFACTION
EHA Library, Jesús Loza, 100157
ON DEATH AND DYING: CULTURAL END-OF-LIFE ISSUES IN MULTIPLE MYELOMA
EHA Library, Marta Pereira, 100158
IN VITRO EXPANDED HUMAN CD4+CD25+FOXP3+ REGULATORY T CELLS IN NUTRIENT-DEPRIVED MEDIUM AS A POTENTIAL ARMAMENT IN THE PREVENTION OF GRAFT-VERSUS-HOST DISEASE
EHA Library, Tzeon-Jye Chiou, 100159
PROGNOSTIC SIGNIFICANCE OF IMMUNOLOGIC RECOVERY AFTER AUTOLOGOUS PERIPHERAL BLOOD STEM CELL TRANSPLANTATION IN PATIENTS WITH LYMPHOMAS
EHA Library, Maria Cioch, 100160
SOLUBLE FMS-LIKE TYROSINE KINASE-1 IN CHILDREN AND ADOLESCENTS WITH THALASSEMIA INTERMEDIA: RELATION TO PULMONARY VASCULOPATHY AND SUBCLINICAL ATHEROSCLEROSIS
EHA Library, AZZA ABDELGAWAD TANTAWY ZAGHLOUL, 100161
UPPER AND LOWER EXTREMITY DEEP VEIN THROMBOSIS IN CHILDREN:A SINGLE CENTER EXPERIENCE
EHA Library, Mualla Cetin, 100162
DEMAND MANAGEMENT OF ANALYTICAL REQUEST IN ERYTHROPATHOGY SECTION OF A TERTIARY HOSPITAL.
EHA Library, María de la O Abío Calvete, 100163
PREDICTIVE POTENTIAL OF MARKERS OF COAGULATION, FIBRINOLYSIS AND ANGIOGENESIS IN CANCER PATIENTS
EHA Library, Elina Beleva, 100164
DURABLE LONG TERM REMISSIONS WITH EARLY USE OF RITUXIMAB IN PATIENTS WITH THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP)
EHA Library, Shahid Iqbal, 100165
ASSESSMENT OF LOW MOLECULAR WEIGHT HEPARIN ANTICOAGULANT EFFECT IN CHILDREN USING THROMBODYNAMICS GLOBAL HEMOSTASIS ASSAY
EHA Library, Pavel Zharkov, 100166
EFFICACY OF THROMBOPROPHYLAXIS IN THE PREVENTION OF THROMBOSIS IN PREGNANCY. EFFECTS ON THE INCIDENCE OF MISCARRIAGES.
EHA Library, Carolina Miranda, 100167
THROMBIN GENERATION (TG) POTENTIAL AND ACTIVATED PROTEIN C (APC) RESISTANCE IN PATIENTS ON CHRONIC ORAL ANTICOAGULANT THERAPY WITH VITAMIN K ANTAGONIST (VKA)
EHA Library, Cristina Verzeroli, 100168
POLYPHARMACY IN PATIENTS TREATED WITH NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS (NOACS) AND THEIR IMPLICATION IN THE PERIOPERATIVE SETTING. RESULTS FROM THE “REAL LIFE” COHORT
EHA Library, Inés Valcarce, 100169
IMMOBILIZATION AS A RISK FACTOR IN VENOUS THROMBOEMOLISM. DIFFERENCES BY SEX AND AGE
EHA Library, Aránzazu García Raso, 100170
PROPHYLAXIS FOR VENOUS THROMBOEMBOLIC DISEASE IN PREGNANCY AND POSTPARTUM PERIOD.
EHA Library, Sofia Grille, 100171
THE CALIBRATED AUTOMATED THROMBOGRAM AS A USEFUL TOOL IN DETERMINATION OF PROTHROMBOTIC PHENOTYPE.
EHA Library, Veronika Shmeleva, 100172
LMWH PROPHYLAXIS THROMBOTIC EVENTS IN HODGKIN LYMPHOMA PATIENTS
EHA Library, Alexander Poletaev, 100173
CATALASE С−262Т GENE POLYMORPHISM AS A POSSIBLE RISK FACTOR FOR VENOUS THROMBOEMBOLISM IN THE POPULATION OF NORTH-WESTERN RUSSIA
EHA Library, Sergey Kapustin, 100174
EVALUATION OF ABO BLOOD GROUP DISCREPANCIES IN A TERTIARY CARE CENTRE IN SPAIN
EHA Library, Maria Tenorio, 100175
USE OF A PEGYLATED CARBOXYHEMOGLOBIN BOVINE IN SEVERE LIFE-THREATENING ANEMIA
EHA Library, Ronald Jubin, 100176
CLINICAL COURSE AND OUTCOME OF NEWLY DIAGNOSED ACUTE LEUKEMIA PATIENTS PRESENTED WITH HYPERLEUKOCYTOSIS IN THAILAND: A 10-YEAR SINGLE-CENTER RETROSPECTIVE STUDY
EHA Library, Archrob Khuhapinant, 100177
DETECTION OF UNEXPECTED RED CELL ALLOANTIBODIES BY THE ENZYME/NACL GEL TEST ONLY
EHA Library, Aspasia Argyrou, 100178
SUCCESSFUL COMPATIBLE PHENOTYPE TRANSFUSION PROTOCOL TO PREVENT ALLOIMMUNIZATION IN SICKLE CELL DISEASE.
EHA Library, Ana Maria Pérez-Corral, 100179
THE MIRNA PROFILE OF PLATELETS STORED IN A BLOOD BANK AND ITS RELATION TO CELLULAR DAMAGE FROM STORAGE
EHA Library, Thais Pontes, 100180
MONITORING HEMOSTATIC POTENTIAL OF PLATELETS DURING STORAGE OF PLATELET CONCENTRATES FOR TRANSFUSION
EHA Library, Cinzia Giaccherini, 100181
INDIVIDUALIZED GCSF/PLERIXAFOR PBSC MOBILIZATION SCHEDULE ALLOWS SUCCESSFUL HARVEST ALSO IN POOR MOBILIZERS LYMPHOMA PATIENTS
EHA Library, Manuela Rizzo, 100182
GENETIC RISK FACTORS IN HUMORAL IMMUNE RESPONSE TO PLATELET ANTIGENS HLA AND HPA SYSTEMS IN MULTITRANSFUSED HEMATOLOGICAL PATIENTS
EHA Library, Larisa Golovkina, 100183
STUDY OF AN ALTERNATIVE PYROGEN TEST FOR BLOOD PRODUCTS USING MONOCYTE ACTIVATION TEST.
EHA Library, Ji Hye Kim, 100184
INFILTRATION OF PLATELET RICH PLASMA OBTAINED IN OPEN SYSTEM IN PATIENTS WITH EPICONDILITIS
EHA Library, Aránzazu García Raso, 100185
COMPARISON OF IRON CHELATION EFFECTS OF DEFEROXAMINE, DEFERASIROX, AND COMBINATION OF DEFEROXAMINE AND DEFERIPRONE ON LIVER AND CARDIAC T2* MRI IN THALASSEMIA MAIOR
EHA Library, Shahla Ansari, 100186
POTENTIAL THERAPEUTIC TARGETS IN PLASMA CELL DISORDERS: A FLOW CYTOMETRY STUDY.
EHA Library, Katharina Lisenko, 100187
A CROSS-SECTIONAL STUDY COMPARING DIFFERENT HEMATOLOGICAL AND BIOCHEMICAL DISEASE MARKERS FOR CLINICAL DIAGNOSIS OF IRON DEFICIENCY
EHA Library, Dietmar Enko, 100188
DIAGNOSIS OF FUNCTIONAL IRON DEFICIENCY: HEPCIDIN AS NOVEL BIOMARKER VERSUS CONVENTIONAL CLINICAL BIOMARKERS
EHA Library, Dietmar Enko, 100189
SUPERVISED MULTI-CLASSIFIER SEPARATION OF THE PH-NEGATIVE MYELOPROLIFERATIVE NEOPLASMS
EHA Library, Vibe Skov, 100190
A MODIFIED-INTERNATIONAL PROGNOSTIC INDEX INCLUDING PRETREATMENT HEMOGLOBIN LEVEL FOR EARLY STAGE EXTRANODAL NK/T CELL LYMPHOMA
EHA Library, Liang Wang, 100191
A 7- GENE SIGNATURE DEPICTS THE BIOCHEMICAL PROFILE OF EARLY PREFIBROTIC MYELOFIBROSIS
EHA Library, Vibe Skov, 100192
IPSET-THROMBOSIS BETTER IDENTIFIES THROMBOSIS FREE SURVIVAL
EHA Library, Omur Gokmen Sevindik, 100193
SOLUBLE FMS LIKE TYROSINE KINASE-1 (SFLT-1) : AN EARLY MARKER FOR GLOMERULAR DYSFUNCTION IN SICKLE CELL NEPHROPATHY
EHA Library, ILHAM YOUSSRY , 100194
IMPACT OF BURDEN OF THALASSEMIA MAJOR ON HEALTH RELATED QUALITY OF LIFE IN OMANI CHILDREN
EHA Library, Surekha Tony, 100195
BLOOD RHEOLOGY DISTURBANCES INCREASES VTE-RISK IN CHILDREN WITH ACUTE LYMPHPBLASTIC LEUKEMIA
EHA Library, Irina Kolesnikova, 100196
LONG TERM SAFETY AND ACTIVITY OF CLADRIBINE IN MUCOSA-ASSOCIATED LYMPHOID TISSUE LYMPHOMA (MALT LYMPHOMA)
EHA Library, Barbara Kiesewetter, 100197
MRI PROSPECTIVE SURVEY ON CARDIAC AND HEPATIC IRON AND CARDIAC FUNCTION IN TRANSFUSION-DEPENDENT THALASSEMIA INTERMEDIA PATIENTS TREATED WITH DESFERRIOXAMINE, DEFERIPRONE AND DEFERASIROX.
EHA Library, Alessia Pepe, 100198
SIGNIFICANT IMPROVEMENT OF SURVIVAL BY T2* MRI IN THALASSEMIA MAJOR
EHA Library, Alessia Pepe, 100199
LEFT VENTRICULAR GLOBAL FUNCTION INDEX AND LEFT VENTRICULAR MASS VOLUME RATIO BY CMR: ASSOCIATION WITH HEART FAILURE AND ARRHYTHMIAS IN THALASSEMIA MAJOR PATIENTS
EHA Library, Alessia Pepe, 100200
VPA AND SAHA TREATMENT DIFFERENTIALLY IMPACT PROTEOME AND ACETYLOME OF ACUTE MYELOID LEUKEMIA HL60 CELLS
EHA Library, Xiaoyu Zhu, 100201
STATIN ADMINISTRATION AND THE RISK FOR NON-HODGKIN LYMPHOMA: A NATIONWIDE POPULATION-BASED CASE-CONTROL STUDY
EHA Library, SHIH-FENG CHO, 100202
THROMBIN INDUCES VASCULAR LEAKAGE THROUGH MACROPHAGE MIGRATION INHIBITORY FACTOR AND AUTOPHAGY DURING SEPSIS
EHA Library, Chiao-Hsuan Chao, 100203
FEATURES OF EBV VIREMIA AND OUTCOMES IN PATIENTS RECEIVED ALLOGENEIC STEM CELL TRANSPLANTATION: A CHINESE MULTICENTER SURVEY
EHA Library, Jia Chen, 100204
BONE MINERAL DENSITY IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA AND POLYCYTHEMIA VERA
EHA Library, Sarah Farmer, 100205
THE USE OF MAGE C1 AND FLOW CYTOMETRY TO DETERMINE AND MONITOR THE MALIGNANT CELL TYPE IN MULTIPLE MYELOMA
EHA Library, Kirsty Wienand, 100206
CLINICAL SIGNIFICANCE OF CIRCULATING MICROPARTICLES IN PH- MYELOPROLIFERATIVE NEOPLASMS (MPN)
EHA Library, Yue Han, 100207
DECITABINE BRIDGING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THE TREATMENT OF MDS RETROSPECTIVE EFFICACY ANALYSIS
EHA Library, Chengcheng Fu, 100208
ORBITAL AND OCULAR ADNEXAL MALT LYMPHOMAS: A LONG-TERM OUTCOME
EHA Library, Sungwoo Park, 100209
COMPARISON BETWEEN HEALTHY DONOR-DERIVED BONE MARROW MESENCHYMAL STEM CELLS BM-MSCS AND HUMANDERMAL FIBROBLASTS: IMPACT ON CLINICAL APPLICATIONS OF HMSCS.
EHA Library, Mohammed Al Bagami, 100210
SINGLE NUCLEOTIDE POLYMORPHISMS IN APOPTOSIS PATHWAY ARE ASSOCIATED WITH RESPONSE TO IMATINIB THERAPY IN CHRONIC MYELOID LEUKEMIA
EHA Library, Jieun Uhm, 100211
SILENCING PROGRESSION OF TUMOR SUPPRESSIVE MICRORNAS ESSENTIALLY CONTRIBUTES TO DEVELOP AGGRESSIVE T-CELL LYMPHOMA
EHA Library, Akihiro Kitadate, 100212
CLINICAL SIGNIFICANCE OF THE DAY 5 PERIPHERAL BLASTS CLEARANCE RATE IN THE EVALUATION OF EARLY TREATMENT RESPONSE AND THE PROGNOSIS FOR AML PATIENTS
EHA Library, Bing Chen, 100213
RUXOLITINIB IN CHRONIC MYELOMONOCYTIC LEUKEMIA AND SYMPTOMATIC SPLENOMEGALY
EHA Library, Klaus Geissler, 100214
POMALIDOMIDE + LOW-DOSE DEXAMETHASONE IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND RENAL IMPAIRMENT: PHASE 1 PHARMACOKINETICS AND SAFETY
EHA Library, Jeffrey Matous, 100215
BONE MARROW-DERIVED MSCS STIMULATED BY IFN-Γ INHIBITED THE GROWTH OF TOXOPLASMA GONDII VIA UP-REGULATION OF GBP1
EHA Library, Qifa Liu, 100216
ITP PATIENTS IN THE ASIA PACIFIC: ARE THEY DIFFERENT?
EHA Library, Beng Chong, 100217
LONG-TERM RESULTS OF PREDNISONE TREATMENT FOR THE ANEMIA OF MYELOFIBROSIS
EHA Library, Juan Carlos Hernandez-Boluda, 100218
HIGH RESOLUTION MELT (HRM) CURVE ANALYSIS OF P53 MUTATIONS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) PATIENTS
EHA Library, Ezzat Elhassadi, 100219

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings